University of Saskatchewan
usask.caTotal trials
238
Active
24
Phase 3
17
Total enrollment
22,994
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 12 of 12 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Ketamine | — | — | — | — | 3 | ||
| Tiotropium | — | — | — | — | — | 2 | |
| Indomethacin 50 MG | — | — | — | — | — | 1 | |
| IV iron | — | — | — | — | — | 1 | |
| 50 mg 89Zr-DFO-Nimotuzumab | — | — | — | — | — | 1 | |
| 1 mg 89Zr-DFO-Nimotuzumab | — | — | — | — | — | 1 | |
| IRE plus checkpoint inhibitor | — | — | — | — | — | 1 | |
| IRE plus Checkpoint Inhibitor plus CpG-ODN | — | — | — | — | — | 1 | |
| NeuroEPO | — | — | — | — | — | 1 | |
| IRDye800CW-nimotuzumab | — | — | — | — | — | 1 | |
| FOLFOXIRI and Bevacizumab | — | — | — | — | — | 1 | |
| Cannabidiol | — | — | — | — | — | 1 |
Next readouts
- 2024-12-31
- 2025-11
- 2025-12-31
- 2026-09
- 2026-09
- 2026-12-31
- 2027-01
- 2027-12
- 2028-12-01
- 2030-03
Top conditions
- Asthma20
- Osteoporosis10
- Sarcopenia7
- Pain7
- Coronary Artery Disease6
- Depression5
- Anesthesia4
- Ketamine4
Frequently asked questions about University of Saskatchewan
- How many clinical trials does University of Saskatchewan have on ClinicalTrials.gov?
- University of Saskatchewan is listed as the lead sponsor on 238 clinical trials in ClinicalTrials.gov, 24 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Saskatchewan's trials are in Phase 3?
- 17 of University of Saskatchewan's trials are in Phase 3, spread across 12 active drug programs.
- What therapeutic areas does University of Saskatchewan focus on?
- University of Saskatchewan's most-studied conditions on ClinicalTrials.gov are Asthma, Osteoporosis, Sarcopenia, Pain, Coronary Artery Disease.
- When are University of Saskatchewan's next clinical trial readouts?
- University of Saskatchewan has 10 upcoming primary-completion readouts tracked here; the soonest is “Three Dimensional Ultrasonographic Detection of Human Ovulation”, expected around 2024-12-31.